Beta Bionics, Inc. share price logo

Beta Bionics, Inc.

NASDAQ: BBNX

Small Cap

$18.96

+0.09

(+0.48%)

as on

Beta Bionics, Inc. Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $18.33
    $19.26
    downward going graph

    3.32%

    Downside

    1.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.80
    $32.71
    downward going graph

    53.59%

    Downside

    72.52%

    Upside

    downward going graph

Beta Bionics, Inc. share price movements today

Previous Close
$18.87
Open
$18.87
Volume
583.2K
Market Cap
$1.0B
Day's Low - High
$18.33 - $19.26
52 Week Low - High
$8.80 - $32.71

Beta Bionics, Inc. Historical Returns

1 Month Return
-4.82 %
3 Month Return
+ 13.13 %
1 Year Return
-14.82 %
3 Year Return
0 %
5 Year Return
0 %

Beta Bionics, Inc. Stock Fundamentals & Key Indicators

Check Beta Bionics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-1.65

Dividend Yield

0.00%

PE Ratio (TTM)

-11.37

Industry PE ratio

-7.81

PEG Ratio

9.25

Return On Equity TTM

-26.30%

Beta Bionics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Bionics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.0BNA-11.3758.31%0.00%
Buy$49.1B-24.16%49.0577.98%0.00%
Buy$110.4B-32.15%21.1666.69%3.31%
StrongBuy$105.6B2.69%28.1065.17%1.29%
StrongBuy$171.0B-16.82%31.3056.80%2.56%

Stock Returns calculator for Beta Bionics, Inc. Stock including INR - Dollar returns

The Beta Bionics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Beta Bionics, Inc. investment value today

Current value as on today

₹92,451

Returns

-₹7,549

(-7.55%)

Returns from Beta Bionics, Inc. Stock

-₹14,825 (-14.82%)

Dollar Impact

₹7,276 (+7.28%)

Analyst Recommendation on Beta Bionics, Inc. Stock

Based on 8 analysts

BUY

62.50%

Buy

37.50%

Hold

0.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Beta Bionics, Inc.. Average target price of $22.5714285714286

Indian Investors' Interest in Beta Bionics, Inc. Stock

Search interest for Beta Bionics, Inc. Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

Beta Bionics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
8
16
20
17
23
27
32
27
32
Gross Profit
5
8
11
8
12
15
18
16
18
Operating Income
-8
-10
-13
-18
-19
-17
-16
-24
-25
EBITDA
-18
-9
-17
-28
-16
-13
-12
-21
-24
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
1
Income Before Tax
-18
-9
-18
-28
-16
-14
-13
-21
-23
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-18
-9
-18
-28
-16
-14
-13
-21
-23
Net Profit Margin
60.62%
53.36%
57.19%
50.86%
53.80%
55.48%
58.98%
59.50%
59.04%

Beta Bionics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
11
65
100
Gross Profit
0
6
35
55
Operating Income
-65
-35
-45
-71
EBITDA
-63
-42
-53
-70
Interest Expense
0
-
-
-
Depreciation
1
1
1
2
Income Before Tax
-64
-44
-54
-73
Income Tax Expense
-
-
-
-
Net Income
-64
-44
-54
-73
Net Profit Margin
100.00%
52.59%
55.11%
55.40%

Beta Bionics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-9
-18
-28
-16
-14
-13
-21
-23
Operating Cash Flow
-6
-9
-14
-19
-13
-8
-8
-23
-14
Investing Cash Flow
-69
15
-29
-179
6
9
0
21
26
Financing Cash Flow
0
-1
56
211
0
2
1
0
1
Change in Cash
-75
4
12
12
-7
3
-6
-1
14

Beta Bionics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-44
-54
-73
Operating Cash Flow
-60
-32
-48
-50
Investing Cash Flow
0
-69
-3
-162
Financing Cash Flow
56
101
55
214
Change in Cash
-4
-1
3
1

Global Institutional Holdings in Beta Bionics, Inc.

Check out the Institutions with significant holdings in Beta Bionics, Inc..

Funds
Holdings
MUTUAL FUND SERIES TRUST
10.94%
Vanguard
3.74%
iShares
3.27%
VANGUARD INDEX FUNDS
3.12%
James E. Flynn
2.45%

Beta Bionics, Inc. News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 09:31 PM

    -

    Beta Bionics secures FDA clearance for Mint patch pump, enhancing its automated insulin delivery portfolio.

    Fri, 01:44 AM

    -

    Beta Bionics closes $172.5M public offering to fund Mint commercialization and corporate needs.

Insights on Beta Bionics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 10.5% return, outperforming this stock by 25.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BBNX stock has moved down by -11.9%

About Beta Bionics, Inc.

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
OrganisationBeta Bionics, Inc.
Headquarters11 Hughes, Irvine, CA, 92618, US
IndustryMedical - Devices
CEOSean T. Saint

Key Management of Beta Bionics, Inc.

Name

Title

Dr. Steven Russell M.D., Ph.D.

Chief Medical Officer

Mr. Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Mr. Sean T. Saint PE

President, CEO & Director

Mr. Stephen H. Feider

CFO, Treasurer & Secretary

Mr. Mike Mensinger

Chief Product Officer

Mr. David Henderson

Vice President of Operations

Blake Beber

Head of Investor Relations

FAQs

What is Beta Bionics, Inc. share price today?

Beta Bionics, Inc. share price today is $18.96 as on at the close of the market. Beta Bionics, Inc. share today touched a day high of $19.26 and a low of $18.33.

What is the 52 week high and 52 week low for Beta Bionics, Inc. share?

Beta Bionics, Inc. share touched a 52 week high of $32.71 on and a 52 week low of $8.80 on . Beta Bionics, Inc. stock price today i.e. is closed at $18.96,which is 42.04% down from its 52 week high and 115.45% up from its 52 week low.

What is Beta Bionics, Inc.'s market capitalisation today?

Beta Bionics, Inc. market capitalisation is $0.00T as on .

How to invest in Beta Bionics, Inc. Stock (BBNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beta Bionics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Beta Bionics, Inc. Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics, Inc. (BBNX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Beta Bionics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Beta Bionics, Inc. share’s latest price of $18.96 as on October 3, 2026 at 8:45 am IST, you will get 0.5274 shares of Beta Bionics, Inc.. Learn more about fractional shares .